Adaptive Biotechnologies Corp <ADPT.O>: Morgan Stanley raises target price to $22 from $20
ADPT•Related News
HNI Q2 sales and adjusted EPS beat analyst expectations
HNI•
ICE to buy MarketAxess for USD 167 a share in cash valuing deal at USD 6 billion
MKTX•
UK's Bicycle Therapeutics Q2 net loss narrows on reduced clinical program expenses
BCYC•
Lincoln Electric Q2 sales rise 12%, beat estimates
LECO•
U.S. Stocks on the Move-Fortinet, Regeneron, Cigna
SPY•